• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有巨噬细胞选择性和可编程性的 DNA 模块化 STING 激动剂,用于增强抗肿瘤免疫治疗。

A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.

机构信息

Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Institute of Molecular Medicine, Shanghai Key Laboratory of Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

出版信息

Adv Sci (Weinh). 2024 Aug;11(32):e2400149. doi: 10.1002/advs.202400149. Epub 2024 Jun 19.

DOI:10.1002/advs.202400149
PMID:38898748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348061/
Abstract

The activation of cyclic GMP-AMP (cGAMP) synthase (cGAS) and its adaptor, stimulator of interferon genes (STING), is known to reprogram the immunosuppressive tumor microenvironment for promoting antitumor immunity. To enhance the efficiency of cGAS-STING pathway activation, macrophage-selective uptake, and programmable cytosolic release are crucial for the delivery of STING agonists. However, existing polymer- or lipid-based delivery systems encounter difficulty in integrating multiple functions meanwhile maintaining precise control and simple procedures. Herein, inspired by cGAS being a natural DNA sensor, a modularized DNA nanodevice agonist (DNDA) is designed that enable macrophage-selective uptake and programmable activation of the cGAS-STING pathway through precise self-assembly. The resulting DNA nanodevice acts as both a nanocarrier and agonist. Upon local administration, it demonstrates the ability of macrophage-selective uptake, endosomal escape, and cytosolic release of the cGAS-recognizing DNA segment, leading to robust activation of the cGAS-STING pathway and enhanced antitumor efficacy. Moreover, DNDA elicits a synergistic therapeutic effect when combined with immune checkpoint blockade. The study broadens the application of DNA nanotechnology as an immune stimulator for cGAS-STING activation.

摘要

环鸟苷酸-腺苷酸(cGAMP)合酶(cGAS)及其衔接蛋白干扰素基因刺激物(STING)的激活被认为可以重新编程免疫抑制性肿瘤微环境,促进抗肿瘤免疫。为了提高 cGAS-STING 途径激活的效率,对于 STING 激动剂的递送来,巨噬细胞选择性摄取和可编程细胞质释放至关重要。然而,现有的聚合物或脂质基递送系统在整合多种功能的同时,难以精确控制和保持简单的程序。受 cGAS 作为天然 DNA 传感器的启发,本文设计了一种模块化 DNA 纳米器件激动剂(DNDA),通过精确的自组装实现了巨噬细胞选择性摄取和可编程激活 cGAS-STING 途径。所得 DNA 纳米器件既作为纳米载体又作为激动剂。局部给药后,它表现出对巨噬细胞选择性摄取、内体逃逸和细胞质中 cGAS 识别 DNA 片段释放的能力,从而强烈激活 cGAS-STING 途径并增强抗肿瘤功效。此外,DNDA 与免疫检查点阻断联合使用可产生协同治疗效果。该研究拓宽了 DNA 纳米技术作为 cGAS-STING 激活的免疫刺激物的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/f039f2e742ec/ADVS-11-2400149-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/30cf01f51877/ADVS-11-2400149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/90532804fe11/ADVS-11-2400149-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/546fc0eddc89/ADVS-11-2400149-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/ff3c3782bdf9/ADVS-11-2400149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/67d8000cda10/ADVS-11-2400149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/c16d7c9e43d1/ADVS-11-2400149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/f039f2e742ec/ADVS-11-2400149-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/30cf01f51877/ADVS-11-2400149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/90532804fe11/ADVS-11-2400149-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/546fc0eddc89/ADVS-11-2400149-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/ff3c3782bdf9/ADVS-11-2400149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/67d8000cda10/ADVS-11-2400149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/c16d7c9e43d1/ADVS-11-2400149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e197/11348061/f039f2e742ec/ADVS-11-2400149-g005.jpg

相似文献

1
A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.一种具有巨噬细胞选择性和可编程性的 DNA 模块化 STING 激动剂,用于增强抗肿瘤免疫治疗。
Adv Sci (Weinh). 2024 Aug;11(32):e2400149. doi: 10.1002/advs.202400149. Epub 2024 Jun 19.
2
A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.一种通用的生物矿化策略,用于合成具有 cGAS-STING 激活能力的自体癌症疫苗,用于术后免疫治疗。
ACS Nano. 2023 Jun 13;17(11):10496-10510. doi: 10.1021/acsnano.3c01404. Epub 2023 May 15.
3
A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy.一种聚合物纳米平台增强巨噬细胞中的cGAS-STING通路,以增强吞噬作用用于癌症免疫治疗。
J Control Release. 2024 Sep;373:447-462. doi: 10.1016/j.jconrel.2024.07.039. Epub 2024 Jul 25.
4
Biodegradable Long-Circulating Nanoagonists Optimize Tumor-Tropism Chemo-Metalloimmunotherapy for Boosted Antitumor Immunity by Cascade cGAS-STING Pathway Activation.可生物降解的长循环纳米激动剂通过级联 cGAS-STING 通路激活优化肿瘤趋向性化疗-金属免疫疗法以增强抗肿瘤免疫
ACS Nano. 2024 Aug 27;18(34):23711-23726. doi: 10.1021/acsnano.4c08463. Epub 2024 Aug 16.
5
Pharmacological Activation of cGAS for Cancer Immunotherapy.cGAS 的药理学激活用于癌症免疫治疗。
Front Immunol. 2021 Nov 26;12:753472. doi: 10.3389/fimmu.2021.753472. eCollection 2021.
6
Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.cGAS-STING 免疫调节剂的工程设计与递送及其在癌症和自身免疫性疾病免疫治疗中的应用。
Acc Chem Res. 2023 Nov 7;56(21):2933-2943. doi: 10.1021/acs.accounts.3c00394. Epub 2023 Oct 6.
7
cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.肿瘤微环境中的cGAS-STING激活及其在癌症免疫中的作用。
Adv Exp Med Biol. 2017;1024:175-194. doi: 10.1007/978-981-10-5987-2_8.
8
The cGAS/STING Pathway: A Novel Target for Cancer Therapy.cGAS/STING 通路:癌症治疗的新靶点。
Front Immunol. 2022 Jan 3;12:795401. doi: 10.3389/fimmu.2021.795401. eCollection 2021.
9
Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.可分解纳米激动剂使近红外光诱导的 cGAS-STING 激活用于串联放大光动力-金属免疫治疗。
Adv Mater. 2024 May;36(21):e2313029. doi: 10.1002/adma.202313029. Epub 2024 Feb 23.
10
Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis.线粒体(mt)DNA-环鸟苷酸-腺苷酸合成酶(cGAS)-干扰素基因刺激物(STING)信号通过干扰素调节因子(IRF)7/IRF3 的激活促进巨噬细胞的细胞焦亡,从而加重重症急性胰腺炎期间的肺损伤。
Cell Mol Biol Lett. 2024 Apr 27;29(1):61. doi: 10.1186/s11658-024-00575-9.

引用本文的文献

1
Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy.利用核酸纳米颗粒的免疫学特性改善癌症治疗
RNA Nanomed. 2025 Apr;2(1). doi: 10.59566/isrnn.2025.0201b.
2
Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer.整合单细胞和批量转录组分析鉴定出一种与乳腺癌预后不良相关的新型巨噬细胞亚型。
Cancer Cell Int. 2025 Mar 27;25(1):119. doi: 10.1186/s12935-025-03750-w.
3
Profile of STING agonist and inhibitor research: a bibliometric analysis.

本文引用的文献

1
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration.锌环二磷酸腺苷纳米颗粒通过内皮细胞中的干扰素基因刺激蛋白(STING)激活和肿瘤相关巨噬细胞的再激活来靶向并抑制肿瘤。
Nat Nanotechnol. 2022 Dec;17(12):1322-1331. doi: 10.1038/s41565-022-01225-x. Epub 2022 Oct 27.
2
Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.锰配位胶束激活干扰素基因刺激物并原位捕获肿瘤抗原用于癌症金属免疫治疗。
ACS Nano. 2022 Oct 25;16(10):16909-16923. doi: 10.1021/acsnano.2c06926. Epub 2022 Oct 6.
3
STING激动剂与抑制剂研究概况:一项文献计量学分析
Front Pharmacol. 2025 Feb 11;16:1528459. doi: 10.3389/fphar.2025.1528459. eCollection 2025.
4
Nanotherapeutics for Macrophage Network Modulation in Tumor Microenvironments: Targets and Tools.肿瘤微环境中巨噬细胞网络调控的纳米疗法:靶点与工具
Int J Nanomedicine. 2024 Dec 19;19:13615-13651. doi: 10.2147/IJN.S491573. eCollection 2024.
Immunogenic Cell Death Augmented by Manganese Zinc Sulfide Nanoparticles for Metastatic Melanoma Immunotherapy.
基于锰锌硫化纳米颗粒的免疫原性细胞死亡增强作用用于转移性黑色素瘤免疫治疗。
ACS Nano. 2022 Sep 27;16(9):15471-15483. doi: 10.1021/acsnano.2c08013. Epub 2022 Aug 18.
4
Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles.基于核苷酸纳米复合物修饰的超声微泡介导的 STING 激活的癌症免疫治疗。
Nat Nanotechnol. 2022 Aug;17(8):891-899. doi: 10.1038/s41565-022-01134-z. Epub 2022 May 30.
5
A Lysosome-Activated Tetrahedral Nanobox for Encapsulated siRNA Delivery.用于封装小干扰RNA递送的溶酶体激活四面体纳米盒
Adv Mater. 2022 Nov;34(46):e2201731. doi: 10.1002/adma.202201731. Epub 2022 Jun 3.
6
Acid-Resistant and Physiological pH-Responsive DNA Hydrogel Composed of A-Motif and i-Motif toward Oral Insulin Delivery.基于 A 型和 i 型双螺旋结构的耐酸性及生理 pH 值响应性 DNA 水凝胶用于口服胰岛素传递。
J Am Chem Soc. 2022 Mar 30;144(12):5461-5470. doi: 10.1021/jacs.1c13426. Epub 2022 Mar 21.
7
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.化学和生物分子策略在癌症免疫治疗中对 STING 通路的激活。
Chem Rev. 2022 Mar 23;122(6):5977-6039. doi: 10.1021/acs.chemrev.1c00750. Epub 2022 Feb 2.
8
Delivery of STING agonists for adjuvanting subunit vaccines.STING 激动剂在佐剂亚单位疫苗中的递送。
Adv Drug Deliv Rev. 2021 Dec;179:114020. doi: 10.1016/j.addr.2021.114020. Epub 2021 Oct 29.
9
Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy.环状二核苷酸-锰颗粒增强 STING 激活用于局部和全身癌症金属免疫治疗。
Nat Nanotechnol. 2021 Nov;16(11):1260-1270. doi: 10.1038/s41565-021-00962-9. Epub 2021 Sep 30.
10
STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity.STING激动剂与基于蛋白质的癌症疫苗联合使用可增强外周和肿瘤内T细胞免疫。
Front Immunol. 2021 Jul 1;12:695056. doi: 10.3389/fimmu.2021.695056. eCollection 2021.